Semler Scientific, Inc. financial data

Symbol
SMLR on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
2340 2348 Walsh Avenue, Suite 2344, Santa Clara, CA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 835 % +31.9%
Quick Ratio 6.2 % +7.83%
Return On Equity 21.2 % -30%
Return On Assets 19.4 % -26.3%
Operating Margin 29.6 % -38.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.13M shares +4.05%
Common Stock, Shares, Outstanding 6.99M shares +4.15%
Entity Public Float 115M USD -26%
Common Stock, Value, Issued 7K USD 0%
Weighted Average Number of Shares Outstanding, Basic 6.94M shares +3.54%
Weighted Average Number of Shares Outstanding, Diluted 7.8M shares -0.91%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 14.5M USD -22.3%
Revenue from Contract with Customer, Excluding Assessed Tax 68.2M USD +20.3%
Cost of Revenue 7M USD +45.6%
Selling and Marketing Expense 15.1M USD -20.5%
General and Administrative Expense 12.8M USD -4.03%
Costs and Expenses 40.6M USD -5.89%
Operating Income (Loss) 21.1M USD -1.73%
Nonoperating Income (Expense) -2.41M USD -280%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 18.7M USD -18%
Income Tax Expense (Benefit) 2.92M USD -43%
Net Income (Loss) Attributable to Parent 15.8M USD -10.8%
Earnings Per Share, Basic 2.32 USD/shares -12.5%
Earnings Per Share, Diluted 2.03 USD/shares -9.78%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.33M USD -81.4%
Accounts Receivable, after Allowance for Credit Loss, Current 7.47M USD +23.8%
Inventory, Net 385K USD -19.1%
Assets, Current 23.7M USD -61%
Deferred Income Tax Assets, Net 3.12M USD +24.7%
Operating Lease, Right-of-Use Asset 108K USD -43.8%
Other Assets, Noncurrent 127K USD -95.4%
Assets 84.8M USD +12.4%
Accounts Payable, Current 227K USD -55.4%
Employee-related Liabilities, Current 2.7M USD -30.2%
Accrued Liabilities, Current 5.09M USD -38.3%
Contract with Customer, Liability, Current 840K USD -29.3%
Liabilities, Current 6.36M USD -36.9%
Operating Lease, Liability, Noncurrent 24K USD -79.3%
Other Liabilities, Noncurrent 24K USD -79.3%
Retained Earnings (Accumulated Deficit) 65.9M USD +31.6%
Stockholders' Equity Attributable to Parent 78.4M USD +20.1%
Liabilities and Equity 84.8M USD +12.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 5.62M USD +553%
Net Cash Provided by (Used in) Financing Activities 11K USD
Net Cash Provided by (Used in) Investing Activities -81K USD +99.6%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 7.2M shares +4.03%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.55M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.46M USD -81.1%
Deferred Tax Assets, Valuation Allowance 1.21M USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 3M USD +27.3%
Operating Lease, Liability 116K USD -42.9%
Depreciation 46K USD +6.98%
Payments to Acquire Property, Plant, and Equipment 4K USD -95.8%
Lessee, Operating Lease, Liability, to be Paid 118K USD -43.5%
Operating Lease, Liability, Current 92K USD +5.75%
Lessee, Operating Lease, Liability, to be Paid, Year Two 71K USD -23.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 71K USD -23.7%
Deferred Income Tax Expense (Benefit) -136K USD -70%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2K USD -66.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 71K USD -23.7%
Deferred Tax Assets, Operating Loss Carryforwards 188K USD -38%
Unrecognized Tax Benefits 580K USD +29.8%
Additional Paid in Capital 12.5M USD -17.7%
Deferred Tax Assets, Net of Valuation Allowance 3M USD +27.3%
Share-based Payment Arrangement, Expense 378K USD -59.2%